{"nct_id":"NCT03564340","title":"Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2018-05-21","start_date_type":"ACTUAL","primary_completion_date":"2026-02-01","primary_completion_date_type":"ESTIMATED","completion_date":"2027-01-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["REGN"]}